SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$8.17
-0.08 (-0.97%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+706.7% upside
Low Target
$44.11
Average Target
$65.91
High Target
$67.85
Current Price
$8.17
Current
$8.17
$8.17
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Scenario Analysis
Bear Case
$44.11
439.9%
Low target
Base Case
$65.91
+706.7%
Avg target
Bull Case
$67.85
+730.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$18.90
-56.8% from high
52-Week Low
$6.66
+22.7% from low
Target vs 52W High
$65.91
+248.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |